Glaxo Agrees To Settle Paxil Litigation For $63.8M

Law360, New York (November 1, 2006, 12:00 AM EST) -- GlaxoSmithKline PLC is dishing out $63.8 million to settle claims in a class action lawsuit that it marketed its antidepressant drug Paxil to kids and teenagers while hiding information about the drug’s safety.

Around $16.6 million of the settlement will go to plaintiffs’ attorneys. The suit was filed in notorious plaintiffs’ haven Madison County, Ill.

As part of the settlement, Glaxo denied the suit’s claims and said that it wanted to resolve the matter to avoid further costs.

A spokeswoman for Glaxo, Mary Anne Rhyne, told...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.